PRLB reports record Q2 2026 revenue and profitability, driven by double-digit growth and margin expansion in injection molding.
Proto Labs (PRLB) announced an 8%-10% revenue growth outlook for 2026, citing acceleration in its injection molding segment. The company reported record Q2 2026 revenue and profitability, with double-digit growth and gross margin expansion.
Results reflect strong operating cost leverage and early momentum in key segments. Prior quarters showed steady performance, but Q2 2026 marks a notable uptick in growth metrics.
Management highlighted the role of injection molding in driving the improved outlook, though no immediate market reaction was specified.